Ashok Kumar Panda

Ashok Kumar Panda

Central Ayurveda Research Institute, Bhubaneswar, Odisha, India

Profile ID RP-000-1019 Joined 2023-01-17 2 articles
1
Total Views
2
Total Publications
1,334
Publication Views

Articles(2)

Authors: Ashok Kumar Panda, Suvendu Rout, Amulya Ratna Biswal, Sarbeswar Kar

DOI: 10.18231/j.jpmhh.2022.003  

Volume8

Issue1

Pages9-15

Abstract

Fatty liver disease is a spectrum of liver disease, from a "bland" fatty infiltration to chronic hepatitis (steatohepatitis or NASH), that can result in cirrhosis, hepato cellular carcinoma and organ failure. The prevalence of fatty liver in India is 9-32% with an average of 25% in general population in India. There is no pharmacological agent being officially approved. Therefore, prevention and stop the progression of fatty liver by life style modification and Ayurveda medication are very acceptable by people now a day. Ayurveda treatment involves diet, yogic intervention, Panchakarma therapy and drug therapy. Ayurveda medication can improve the hepatic lipid metabolism, stop hepatic lipogenesis, regulate the mitochondrial dysfunction, modulate lipid metabolism by bile synthesis, modulate the hepatic inflammation through apoptosis and autophagy, correction of gut bacterial composition. The few evidences suggested to practice and generate more data for prevention and arrest the progression of fatty liver diseases. Keywords: Panchakarma, Ayurveda, Microbata.

Open full article page

Authors: Ashok Kumar Panda, Dipti Tarini Palei, Suvendu Rout, Sarbeswar Kar

DOI: 10.18231/j.jpmhh.2021.020  

Volume7

Issue2

Pages104-108

Abstract

Ayurveda is a live traditional system of medicine with an unbreakable practice since 3000 years. Its principles and its approaches including oral administration of preventive drugs, herbs, formulae, decoction, indoor herbal medicine for fumigation, etc. were recommended for effective prevention and treatment whenever the emergent of new diseases. This paper highlights the patho-physiology of Corona as per Ayurveda, Clinical staging, preventive and curative approaches as learned time to time. and Anu taila nasya have excellent practice evidences for prevention of Covid-19 in 1 wave of corona. Sajeevani app developed by AYUSH to study the AYUSH practices. AYUSH -64 is an evidence-based treatment to cure mild to moderate COVID infection developed by Central Council for Research in Ayurveda Sciences. The second wave of COVID-19 is more tragedy than 1 wave and its impact on health care systems of our nation is devastating and unprecedented. National campaign for AYUSH-64 started and it is recommended in National Clinical Management Protocol based on Ayurveda and Yoga which is vetted by National Task Force on COVID management for COVID-19 Patients in Home Isolation. All Institute of Ayurveda released list of medicines for management of various symptoms of Covid. General public have more trusted upon Ayurveda practitioners as controversies of addition and deletion of steroid and antiviral in modern treatment protocol. The horror of Black (Mucormycosis) and white (Candiditis) fungus infection due to irrational use of immunosuppressive drugs confused the general people. More numbers of Covid patients received AYUSH-64 in 2 wave. Ayurveda Practice requires sound knowledge of Yukti Pramana(Logic and self judgement) by discerning clinical for better outcome irrespective of evidences and guidelines. We all are learning the pathogenesis of different mutants of Covid. Ayurveda approaches reduced the complication and progression of disease. This review will provide basic understanding Ayurveda for covid care. Keywords: COVID-19, Ayurveda Principle, Jvara(Fever), Dhatugata Jvara, Janapadadhamsa( epidemic). AYUSH-64.

Open full article page

No matching articles

Try another word from the title, author or DOI.